Challenges associated with ceftriaxone resistance in Salmonella

References

• Alexander KA, Warnick LD, Wiedmann M. 2009. Antimicrobial resistant Salmonella in dairy cattle in the United States. Vet Res Commun. 33(3):191–209. doi: 10.1007/s11259-008-9170-7
   Google Scholar
• Al-Mashhadani M, Hewson R, Vivancos R, Keenan A, Beeching NJ, Wain J, Parry CM. 2011. Foreign travel and decreased ciprofloxacin susceptibility in Salmonella enterica infections. Emerg Infect Dis. 17(1):123–125. doi: 10.3201/eid1701.100999
   Google Scholar
• Ao TT, Feasey NA, Gordon MA, Keddy KH, Angulo FJ, Crump JA. 2015. Global burden of invasive nontyphoidal Salmonella disease, 2010(1). Emerg Infect Dis. 21(6):941–949. doi: 10.3201/eid2106.140999
   Google Scholar
• Arlet G, Barrett TJ, Butaye P, Cloeckaert A, Mulvey MR, White DG. 2006. Salmonella resistant to extended-spectrum cephalosporins: prevalence and epidemiology. Microbes Infect. 8(7):1945–1954. doi: 10.1016/j.micinf.2005.12.029
   Google Scholar
• Barriere SL, Flaherty JF. 1984. Third-generation cephalosporins: a critical evaluation. Clin Pharmacol. 3(4):351–373.
   Google Scholar
• Butler T. 2011. Treatment of typhoid fever in the 21st century: promises and shortcomings. Clin Microbiol Infec. 17(7):959–963. doi: 10.1111/j.1469-0691.2011.03552.x
   Google Scholar
• CDC. 2013. National antimicrobial resistance monitoring system for enteric bacteria (NARMS): the 2011 NARMS annual human isolates report.
   Google Scholar
• Chen HM, Wang Y, Su LH, Chiu CH. 2013. Nontyphoid salmonella infection: microbiology, clinical features, and antimicrobial therapy. Pediatr Neonatol. 54(3):147–152. doi: 10.1016/j.pedneo.2013.01.010
   Google Scholar
• Cruchaga S, Echeita A, Aladuena A, Garcia-Pena J, Frias N, Usera MA. 2001. Antimicrobial resistance in salmonellae from humans, food and animals in Spain in 1998. J Antimicrob Chemother. 47(3):315–321. doi: 10.1093/jac/47.3.315
   Google Scholar
• Crump JA, Luby SP, Mintz ED. 2004. The global burden of typhoid fever. Bull World Health Organ. 82(5):346–353.
   Google Scholar
• Crump JA, Medalla FM, Joyce KW, Krueger AL, Hoekstra RM, Whichard JM, Barzilay EJ, Emerging Infections Program NWG. 2011. Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: national antimicrobial resistance monitoring system, 1996 to 2007. Antimicrob Agents Chemother. 55(3):1148–1154. doi: 10.1128/AAC.01333-10
   Google Scholar
• Dave J, Sefton A. 2015. Enteric fever and its impact on returning travellers. Int Health. 7(3):163–168. doi: 10.1093/inthealth/ihv018
   Google Scholar
• Davies J, Davies D. 2010. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 74(3):417–433. doi: 10.1128/MMBR.00016-10
   Google Scholar
• Dunne EF, Fey PD, Kludt P, Reporter R, Mostashari F, Shillam P, Wicklund J, Miller C, Holland B, Stamey K. 2000. Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC β-lactamase. JAMA. 284(24):3151–3156. doi: 10.1001/jama.284.24.3151
   Google Scholar
• Egorova S, Timinouni M, Demartin M, Granier SA, Whichard JM, Sangal V, Fabre L, Delaune A, Pardos M, Millemann Y, et al. 2008. Ceftriaxone-resistant salmonella enterica serotype Newport. France. Emerg Infect Dis. 14(6):954–957. doi: 10.3201/eid1406.071168
   Google Scholar
• Eng S-K, Pusparajah P, Ab Mutalib N-S, Ser H-L, Chan K-G, Lee L-H. 2015. Salmonella: A review on pathogenesis, epidemiology and antibiotic resistance. Front Life Sci. 8(3):284–293. doi: 10.1080/21553769.2015.1051243
   Google Scholar
• Engels EA, Falagas ME, Lau J, Bennish ML. 1998. Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity. Br Med J. 316(7125):110–116. doi: 10.1136/bmj.316.7125.110
   Google Scholar
• Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA. 2012. Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet. 379(9835):2489–2499. doi: 10.1016/S0140-6736(11)61752-2
   Google Scholar
• Fey PD, Safranek TJ, Rupp ME, Dunne EF, Ribot E, Iwen PC, Bradford PA, Angulo FJ, Hinrichs SH. 2000. Ceftriaxone-resistant salmonella infection acquired by a child from cattle. Eng J Med. 342(17):1242–1249. doi: 10.1056/NEJM200004273421703
   Google Scholar
• Fullybright R. 2016. The slippery difficulty of ever containing drug resistance with current practices. Eur J Clin Microbiol Infect Dis. 36(4):603–609. doi: 10.1007/s10096-016-2855-x
   Google Scholar
• Germanier R, Fuer E. 1975. Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J Infect Dis. 131(5):553–558. doi: 10.1093/infdis/131.5.553
   Google Scholar
• Hall MJ, Westmacott D, Wong-Kai-In P. 1981. Comparative in-vitro activity and mode of action of ceftriaxone (Ro 13-9904), a new highly potent cephalosporin. J Antimicrob Chemother. 8(3):193–203. doi: 10.1093/jac/8.3.193
   Google Scholar
• Hamilton RD, Hulsebus HJ, Akbar S, Gray JT. 2012. Increased resistance to multiple antimicrobials and altered resistance gene expression in CMY-2-positive Salmonella enterica following a simulated patient treatment with ceftriaxone. Appl Environ Microbiol. 78(22):8062–8066. doi: 10.1128/AEM.02077-12
   Google Scholar
• Hendriksen RS, Mikoleit M, Carlson VP, Karlsmose S, Vieira AR, Jensen AB, Seyfarth AM, DeLong SM, Weill F-X, Wong DMALF. 2009. WHO global salm-surv external quality assurance system for serotyping of Salmonella isolates from 2000 to 2007. J Clin Microbiol. 47(9):2729–2736. doi: 10.1128/JCM.02437-08
   Google Scholar
• Jackson BR, Griffin PM, Cole D, Walsh KA, Chai SJ. 2013. Outbreak-associated Salmonella enterica serotypes and food commodities, United States, 1998–2008. Emerg Infect Dis. 19(8):1239–1244. doi: 10.3201/eid1908.121511
   Google Scholar
• John TJ. 2011. Efficacy and safety of azithromycin for typhoid fever. Indian J Pediatr. 48(10):823–824.
   Google Scholar
• Kariuki S, Gordon MA, Feasey N, Parry CM. 2015. Antimicrobial resistance and management of invasive Salmonella disease. Vaccine. 33(Suppl 3):C21–C29. doi: 10.1016/j.vaccine.2015.03.102
   Google Scholar
• Kariuki S, Okoro C, Kiiru J, Njoroge S, Omuse G, Langridge G, Kingsley RA, Dougan G, Revathi G. 2015. Ceftriaxone-resistant Salmonella enterica serotype typhimurium sequence type 313 from Kenyan patients is associated with the blaCTX-M-15 gene on a novel IncHI2 plasmid. Antimicrob Agents Chemother. 59(6):3133–3139. doi: 10.1128/AAC.00078-15
   Google Scholar
• Krueger AL, Greene SA, Barzilay EJ, Henao O, Vugia D, Hanna S, Meyer S, Smith K, Pecic G, Hoefer D, et al. 2014. Clinical outcomes of nalidixic acid, ceftriaxone, and multidrug-resistant nontyphoidal salmonella infections compared with pansusceptible infections in FoodNet sites, 2006–2008. Foodborne Pathog Dis. 11(5):335–341. doi: 10.1089/fpd.2013.1642
   Google Scholar
• Kumar S, Rizvi M, Berry N. 2008. Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. J Med Microbiol. 57(10):1247–1250. doi: 10.1099/jmm.0.2008/001719-0
   Google Scholar
• Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 10(9):597–602. doi: 10.1016/S1473-3099(10)70143-2
   Google Scholar
• Lebens M, Karlsson SL, Kallgard S, Blomquist M, Ekman A, Nygren E, Holmgren J. 2011. Construction of novel vaccine strains of vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens. Vaccine. 29(43):7505–7513. doi: 10.1016/j.vaccine.2011.06.121
   Google Scholar
• Li XZ, Mehrotra M, Ghimire S, Adewoye L. 2007. Beta-Lactam resistance and beta-lactamases in bacteria of animal origin. Vet Microbiol. 121(3-4):197–214. doi: 10.1016/j.vetmic.2007.01.015
   Google Scholar
• Lin D, Chen K, Wai-Chi Chan E, Chen S. 2015. Increasing prevalence of ciprofloxacin-resistant food-borne Salmonella strains harboring multiple PMQR elements but not target gene mutations. Sci Rep. 5:14754. doi: 10.1038/srep14754
   Google Scholar
• Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, O'Brien SJ, Jones TF, Fazil A, Hoekstra RM. 2010. International collaboration on enteric disease ‘Burden of Illness S. 2010. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis. 50(6):882–889. doi: 10.1086/650733
   Google Scholar
• Majtan J, Majtanova L, Majtan V. 2010. Increasing trend of resistance to nalidixic acid and emerging ceftriaxone and ciprofloxacin resistance in salmonella enterica serovar Typhimurium in Slovakia, 2005 to 2009. Diag Microb Infect Dis. 68(1):86–88. doi: 10.1016/j.diagmicrobio.2010.04.009
   Google Scholar
• Martin LB. 2012. Vaccines for typhoid fever and other Salmonelloses. Curr Opin Infect Dis. 25(5):489–499. doi: 10.1097/QCO.0b013e328356ffeb
   Google Scholar
• Medalla F, Hoekstra RM, Whichard JM, Barzilay EJ, Chiller TM, Joyce K, Rickert R, Krueger A, Stuart A, Griffin PM. 2013. Increase in resistance to ceftriaxone and nonsusceptibility to ciprofloxacin and decrease in multidrug resistance among Salmonella strains, United States, 1996–2009. Foodborne Pathog Dis. 10(4):302–309. doi: 10.1089/fpd.2012.1336
   Google Scholar
• Michael GB, Butaye P, Cloeckaert A, Schwarz S. 2006. Genes and mutations conferring antimicrobial resistance in Salmonella: an update. Microbes Infect. 8(7):1898–1914. doi: 10.1016/j.micinf.2005.12.019
   Google Scholar
• Mtove G, Amos B, Nadjm B, Hendriksen IC, Dondorp AM, Mwambuli A, Kim DR, Ochiai RL, Clemens JD, von Seidlein L, et al. 2011. Decreasing incidence of severe malaria and community-acquired bacteraemia among hospitalized children in Muheza, north-eastern Tanzania, 2006–2010. Malaria J. 10:320. doi: 10.1186/1475-2875-10-320
   Google Scholar
• Nastasi A, Mammina C, Cannova L. 2000. Antimicrobial resistance in Salmonella enteritidis, Southern Italy, 1990–1998. Emerg Infect Dis. 6(4):401–403. doi: 10.3201/eid0604.000415
   Google Scholar
• Olaitan AO, Dia NM, Gautret P, Benkouiten S, Belhouchat K, Drali T, Parola P, Brouqui P, Memish Z, Raoult D, et al. 2015. Acquisition of extended-spectrum cephalosporin- and colistin-resistant Salmonella enterica subsp. enterica serotype Newport by pilgrims during Hajj. Int J Antimicrob Agents. 45(6):600–604. doi: 10.1016/j.ijantimicag.2015.01.010
   Google Scholar
• Oneko M, Kariuki S, Muturi-Kioi V, Otieno K, Otieno VO, Williamson JM, Folster J, Parsons MB, Slutsker L, Mahon BE, et al. 2015. Emergence of community-acquired, multidrug-resistant invasive nontyphoidal Salmonella disease in rural western Kenya, 2009–2013. Clin Infect Dis. 61(Suppl 4):S310–S316. doi: 10.1093/cid/civ674
   Google Scholar
• Patel IH, Kaplan SA. 1984. Pharmacokinetic profile of ceftriaxone in man. Am J Med. 77(4C):17–25.
   Google Scholar
• Pham TD, Karkey A, Dongol S, Ho Thi N, Thompson CN, Rabaa MA, Arjyal A, Holt KE, Wong V, Tran Vu Thieu N, et al. 2016. A novel ciprofloxacin-resistant subclade of H58 Salmonella Typhi is associated with fluoroquinolone treatment failure. eLife. 5:e14003.
   Google Scholar
• Qamar FN, Azmatullah A, Kazi AM, Khan E, Zaidi AK. 2014. A three-year review of antimicrobial resistance of Salmonella enterica serovars Typhi and Paratyphi A in Pakistan. J Infect Dev Countr. 8(8):981–986.
   Google Scholar
• Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. 2014. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New Microbes New Infect. 2(4):88–92. doi: 10.1002/nmi2.46
   Google Scholar
• Rotimi VO, Jamal W, Pal T, Sovenned A, Albert MJ. 2008. Emergence of CTX-M-15 type extended-spectrum β-lactamase-producing Salmonella spp. in Kuwait and the United Arab Emirates. J Med Microbiol. 57(7):881–886. doi: 10.1099/jmm.0.47509-0
   Google Scholar
• Saha SK, Talukder SY, Islam M, Saha S. 1999. A highly ceftriaxone-resistant Salmonella typhi in Bangladesh. Pediatric Infect Dis J. 18(4):387. doi: 10.1097/00006454-199904000-00018
   Google Scholar
• Salmon-Rousseau A, Piednoir E, Cattoir V, de La Blanchardière A. 2016. Hajj-associated infections. Med Maladies Infect. 46(7):346–354. doi: 10.1016/j.medmal.2016.04.002
   Google Scholar
• Smith S, Seriki A, Ajayi A. 2016. Typhoidal and non-typhoidal Salmonella infections in Africa. EJCMID. 35(12):1913–1922. doi: 10.1007/s10096-016-2760-3
   Google Scholar
• Su LH, Chiu CH, Chu C, Ou JT. 2004. Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge. Clin Infec Dis. 39(4):546–551. doi: 10.1086/422726
   Google Scholar
• Su LH, Chiu CH, Chu C, Wang MH, Chia JH, Wu TL. 2003. In vivo acquisition of ceftriaxone resistance in Salmonella enterica serotype anatum. Antimicrob Agents Chemother. 47(2):563–567. doi: 10.1128/AAC.47.2.563-567.2003
   Google Scholar
• Tacket CO, Ferreccio C, Robbins JB, Tsai CM, Schulz D, Cadoz M, Goudeau A, Levine MM. 1986. Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines. J Infect Dis. 154(2):342–345. doi: 10.1093/infdis/154.2.342
   Google Scholar
• Takem EN, Roca A, Cunnington A. 2014. The association between malaria and non-typhoid salmonella bacteraemia in children in sub-saharan Africa: a literature review. Malaria J. 13:400. doi: 10.1186/1475-2875-13-400
   Google Scholar
• Tennant SM, Wang JY, Galen JE, Simon R, Pasetti MF, Gat O, Levine MM. 2011. Engineering and preclinical evaluation of attenuated nontyphoidal salmonella strains serving as live oral vaccines and as reagent strains. Infect Immun. 79(10):4175–4185. doi: 10.1128/IAI.05278-11
   Google Scholar
• Tennant SM, Zhang Y, Galen JE, Geddes CD, Levine MM. 2011. Ultra-fast and sensitive detection of non-typhoidal Salmonella using microwave-accelerated metal-enhanced fluorescence (“MAMEF”). PloS One. 6(4):e18700. doi: 10.1371/journal.pone.0018700
   Google Scholar
• Valdez Y, Ferreira RB, Finlay BB. 2009. Molecular mechanisms of Salmonella virulence and host resistance. Curr Top Microbiol Immunol. 337:93–127.
   Google Scholar
• Van TTH, Nguyen HNK, Smooker PM, Coloe PJ. 2012. The antibiotic resistance characteristics of non-typhoidal Salmonella enterica isolated from food-producing animals, retail meat and humans in South East Asia. Int J Food Microbiol. 154(3):98–106. doi: 10.1016/j.ijfoodmicro.2011.12.032
   Google Scholar
• van der Bij AK, Pitout JD. 2012. The role of international travel in the worldwide spread of multiresistant enterobacteriaceae. J Antimicrob Chemother. 67(9):2090–2100. doi: 10.1093/jac/dks214
   Google Scholar
• Velge P, Wiedemann A, Rosselin M, Abed N, Boumart Z, Chausse AM, Grepinet O, Namdari F, Roche SM, Rossignol A, et al. 2012. Multiplicity of Salmonella entry mechanisms, a new paradigm for Salmonella pathogenesis. MicrobiologyOpen. 1(3):243–258. doi: 10.1002/mbo3.28
   Google Scholar
• Voetsch AC, Van Gilder TJ, Angulo FJ, Farley MM, Shallow S, Marcus R, Cieslak PR, Deneen VC, Tauxe RV. 2004. Emerging infections Program FoodNet Working G. 2004. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis. 38(Suppl 3):S127–S134. doi: 10.1086/381578
   Google Scholar
• Wiedemann A, Virlogeux-Payant I, Chausse AM, Schikora A, Velge P. 2014. Interactions of Salmonella with animals and plants. Frontiers Microbiol. 5:791.
   Google Scholar
• Wise EM, Park JT. 1965. Penicillin: its basic site of action as an inhibitor of a peptide cross-linking reaction in cell wall mucopeptide synthesis. PNAS. 54(1):75–81. doi: 10.1073/pnas.54.1.75
   Google Scholar
• Wong MH, Yan M, Chan EW, Biao K, Chen S. 2014. Emergence of clinical Salmonella enterica serovar Typhimurium isolates with concurrent resistance to ciprofloxacin, ceftriaxone, and azithromycin. Antimicrob Agents Chemother. 58(7):3752–3756. doi: 10.1128/AAC.02770-13
   Google Scholar
• Wong MH, Zeng L, Liu JH, Chen S. 2013. Characterization of Salmonella food isolates with concurrent resistance to ceftriaxone and ciprofloxacin. Foodborne Pathog Dis. 10(1):42–46. doi: 10.1089/fpd.2012.1266
   Google Scholar
• Yan JJ, Chiu CH, Ko WC, Chuang CL, Wu JJ. 2002. Ceftriaxone-resistant Salmonella enterica serovar Hadar: evidence for interspecies transfer of blaCMY-2 in a Taiwanese university hospital. J Formos Med Assoc. 101(9):665–668.
   Google Scholar
• Yan JJ, Ko WC, Chiu CH, Tsai SH, Wu HM, Wu JJ. 2003. Emergence of ceftriaxone-resistant Salmonella isolates and rapid spread of plasmid-encoded CMY-2-like cephalosporinase. Taiwan. Emerg Infect Dis. 9(3):323–328.
   Google Scholar
• Yang WC, Chan OW, Wu TL, Chen CL, Su LH, Chiu CH. 2016. Development of ceftriaxone resistance in Salmonella enterica serotype oranienburg during therapy for bacteremia. J Microb Immunol Infect. 49(1):41–45. doi: 10.1016/j.jmii.2014.01.011
   Google Scholar
• Yang B, Wang Q, Cui S, Wang Y, Shi C, Xia X, Xi M, Wang X, Shi X, Wang D, et al. 2014. Characterization of extended-spectrum beta-lactamases-producing salmonella strains isolated from retail foods in Shaanxi and Henan Province, China. Food Microbiol. 42:14–18. doi: 10.1016/j.fm.2014.02.003
   Google Scholar
• Yates C, Amyes S. 2005. Extended-spectrum β-lactamases in non-typhoidal Salmonella spp. isolated in the UK are now a reality: why the late arrival? JAC. 56(2):262–264.
   Google Scholar
• Yildirmak T, Yazgan A, Ozcengiz G. 1998. Multiple drug resistance patterns and plasmid profiles of non-typhi salmonellae in Turkey. Epidemiol Infect. 121(2):303–307. doi: 10.1017/S0950268898001253
   Google Scholar
• Zaki SA, Karande S. 2011. Multidrug-resistant typhoid fever: a review. J Infect Dev Countr. 5(5):324–337.
   Google Scholar
• Zowawi HM, Balkhy HH, Walsh TR, Paterson DL. 2013. β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula. Clin Microb Rev. 26(3):361–380. doi: 10.1128/CMR.00096-12
   Google Scholar